Anti-Anaerobic Antibiotics Reduce Empyema-Associated Readmissions

Treating empyema with anti-anaerobic antibiotics may lower rates of associated rehospitalization in patients, ...

FEBRUARY 23, 2023

Frailty Screening Predicts CAP Severity in Older Patients

Co-occurring dysphagia and sarcopenia—or frailty—is common, and may predict disease severity of CAP ...

FEBRUARY 17, 2023

High Rates of PrEP Adherence and Persistence for F/TAF Patients

Patients who are naive to HIV PrEP and prescribed Descovy (Gilead) have a greater number of prescription ...

DECEMBER 19, 2022

Knowledge of RSV Low Among Long-Term Care Residents—HCP-Led Educational Sessions May Help

While knowledge regarding RSV infection is low among residents of long-term care facilities, educational sessions ...

DECEMBER 16, 2022

PrEP Awareness High, but Use Low, Among Black and Hispanic Men in U.S.

Awareness of daily oral HIV PrEP is high among Black and Hispanic men in the United States, yet use remains low, ...

DECEMBER 8, 2022

Automated Monitoring Increases Hand Hygiene Performance

Implementation of an automated hand hygiene monitoring system can increase hand sanitizer usage and general hand ...

DECEMBER 7, 2022

Avycaz, a Viable Alternative to Zerbaxa for P. aeruginosa Infections

Ceftazidime-avibactam (C/A; Avycaz, Allergan) may be a viable, effective treatment alternative to ...

DECEMBER 5, 2022

Worse CDI Outcomes for Minority Patients

Racially and ethnically minoritized persons are more likely to develop severe CDI and have worse clinical outcomes, ...

DECEMBER 5, 2022

Prevalence of Drug-Resistant Pathogens May Be Underestimated

The prevalence of drug-resistant pathogens in a patient population may be underestimated when calculated using the ...

DECEMBER 2, 2022

New START Data Reinforces Benefits of Early ART

New START data confirm that starting antiretroviral treatment (ART) early in the course of HIV infection when the ...

NOVEMBER 14, 2022

Sterile Water Protocol Effective in Reducing NTM Outbreak

The formation of a multidisciplinary team and the implementation of a sterile water protocol decreased cases of ...

NOVEMBER 10, 2022

Novel Biotherapeutic Safe, Efficacious in Treating Recurrent CDI

RBX2660, a novel microbiota-based live biotherapeutic, consistently reduced rCDI among patients who are 65 years of ...

NOVEMBER 1, 2022